Insider · CIK 0001266490
Rik J Deitsch
Files at NPHC (NUTRA PHARMA CORP). First filing -, latest -.
In brief
Rik J Deitsch files SEC Form 4 as 10% owner at NPHC (NUTRA PHARMA CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rik J Deitsch has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | NPHC NUTRA PHARMA CORP | GGift Series B Preferred Stock | -12,000,000 | $0.00 | $0 | 0 | 43 d ago |
Questions about Rik J Deitsch
Answered from the filings on this page, as of the latest one.
Is Rik J Deitsch buying or selling?
Rik J Deitsch has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rik J Deitsch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rik J Deitsch has 0.
Where does Rik J Deitsch file Form 4?
Rik J Deitsch has filed Form 4 at NPHC (NUTRA PHARMA CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.